107 related articles for article (PubMed ID: 12803047)
21. Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg.
Danesi R; Lupetti A; Barbara C; Ghelardi E; Chella A; Malizia T; Senesi S; Angeletti CA; Del Tacca M; Campa M
J Antimicrob Chemother; 2003 Apr; 51(4):939-45. PubMed ID: 12654753
[TBL] [Abstract][Full Text] [Related]
22. Propagation of error in ocular pharmacokinetic parameters estimate of azithromycin in rabbits.
You L; Qian J; Wu X; Sun X; Su M; Di B; Du Y; Mao B
J Pharm Sci; 2013 Jul; 102(7):2371-9. PubMed ID: 23649959
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacokinetic effects of antibiotics on the development of bacterial resistance particularly in reference to azithromycin].
Wenisch C
Wien Med Wochenschr; 2000; 150(3):37-41. PubMed ID: 10756595
[TBL] [Abstract][Full Text] [Related]
24. Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin.
Matijašić M; Munić Kos V; Nujić K; Cužić S; Padovan J; Kragol G; Alihodžić S; Mildner B; Verbanac D; Eraković Haber V
Pharmacol Res; 2012 Oct; 66(4):332-42. PubMed ID: 22749903
[TBL] [Abstract][Full Text] [Related]
25. Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen.
Liu P; Allaudeen H; Chandra R; Phillips K; Jungnik A; Breen JD; Sharma A
Antimicrob Agents Chemother; 2007 Jan; 51(1):103-9. PubMed ID: 17060516
[TBL] [Abstract][Full Text] [Related]
26. Maternal-amniotic-fetal distribution of macrolide antibiotics following intravenous, intramuscular, and intraamniotic administration in late pregnant sheep.
Keelan JA; Nitsos I; Saito M; Musk GC; Kemp MW; Timmins M; Li S; Yaegashi N; Newnham JP
Am J Obstet Gynecol; 2011 Jun; 204(6):546.e10-7. PubMed ID: 21481833
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains.
Treyaprasert W; Schmidt S; Rand KH; Suvanakoot U; Derendorf H
Int J Antimicrob Agents; 2007 Mar; 29(3):263-70. PubMed ID: 17194570
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
[TBL] [Abstract][Full Text] [Related]
29. Azithromycin: mechanisms of action and their relevance for clinical applications.
Parnham MJ; Erakovic Haber V; Giamarellos-Bourboulis EJ; Perletti G; Verleden GM; Vos R
Pharmacol Ther; 2014 Aug; 143(2):225-45. PubMed ID: 24631273
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of azithromycin after intravenous and intramuscular administration to goats.
Cárceles CM; Font A; Espuny A; Fernández-Varón E; Serrano JM; Escudero E
J Vet Pharmacol Ther; 2005 Feb; 28(1):51-5. PubMed ID: 15720515
[TBL] [Abstract][Full Text] [Related]
31. Azithromycin iv pharmacodynamic parameters predicting Streptococcus pneumoniae killing in epithelial lining fluid versus serum: an in vitro pharmacodynamic simulation.
Sevillano D; Alou L; Aguilar L; Echevarría O; Giménez MJ; Prieto J
J Antimicrob Chemother; 2006 Jun; 57(6):1128-33. PubMed ID: 16617063
[TBL] [Abstract][Full Text] [Related]
32. Lysosomal alterations induced in cultured rat fibroblasts by long-term exposure to low concentrations of azithromycin.
Van Bambeke F; Gerbaux C; Michot JM; d'Yvoire MB; Montenez JP; Tulkens PM
J Antimicrob Chemother; 1998 Dec; 42(6):761-7. PubMed ID: 10052900
[TBL] [Abstract][Full Text] [Related]
33. Azithromycin effective in preventing MAC.
AIDS Alert; 1996 Oct; 11(10):120. PubMed ID: 11363857
[TBL] [Abstract][Full Text] [Related]
34. Accumulation and clearance of orally administered erythromycin and its derivative, azithromycin, in juvenile fall chinook salmon Oncorhynchus tshawytscha.
Fairgrieve WT; Masada CL; McAuley WC; Peterson ME; Myers MS; Strom MS
Dis Aquat Organ; 2005 Apr; 64(2):99-106. PubMed ID: 15918472
[TBL] [Abstract][Full Text] [Related]
35. Rationale for single and high dose treatment regimens with azithromycin.
Gordon EM; Blumer JL
Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S102-7. PubMed ID: 14770072
[TBL] [Abstract][Full Text] [Related]
36. Azithromycin versus penicillin G benzathine for early syphilis.
Chen XS
Sex Transm Dis; 2012 Nov; 39(11):900-1. PubMed ID: 23060081
[No Abstract] [Full Text] [Related]
37. Comparative pharmacokinetic and relative bioavailability study of coated and uncoated azithromycin powder for suspension in healthy Bangladeshi male volunteers.
Sultana TA; Islam MS; Bhuiyan NH; Shohag MH; Ahmed MU; Naznin SR; Al Maruf A; Huq SM; Hasnat A
Arzneimittelforschung; 2011; 61(10):594-8. PubMed ID: 22164968
[TBL] [Abstract][Full Text] [Related]
38. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin.
Kuehne JJ; Yu AL; Holland GN; Ramaswamy A; Taban R; Mondino BJ; Yu F; Rayner SA; Giese MJ
Am J Ophthalmol; 2004 Oct; 138(4):547-53. PubMed ID: 15488779
[TBL] [Abstract][Full Text] [Related]
39. [Use of azithromycin in the treatment of acute otitis media and tonsillopharyngitis: summary and conclusions.
Klein JO; Schaad UB
Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S140-1. PubMed ID: 14770078
[No Abstract] [Full Text] [Related]
40. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen.
Tribble DR; Sanders JW; Pang LW; Mason C; Pitarangsi C; Baqar S; Armstrong A; Hshieh P; Fox A; Maley EA; Lebron C; Faix DJ; Lawler JV; Nayak G; Lewis M; Bodhidatta L; Scott DA
Clin Infect Dis; 2007 Feb; 44(3):338-46. PubMed ID: 17205438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
